Gallanis, G.T.; Sharif, G.M.; Schmidt, M.O.; Friedland, B.N.; Battina, R.; Rahhal, R.; Davis, J.E., Jr.; Khan, I.S.; Wellstein, A.; Riegel, A.T.
Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells. Cancers 2023, 15, 1908.
https://doi.org/10.3390/cancers15061908
AMA Style
Gallanis GT, Sharif GM, Schmidt MO, Friedland BN, Battina R, Rahhal R, Davis JE Jr., Khan IS, Wellstein A, Riegel AT.
Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells. Cancers. 2023; 15(6):1908.
https://doi.org/10.3390/cancers15061908
Chicago/Turabian Style
Gallanis, Gregory T., Ghada M. Sharif, Marcel O. Schmidt, Benjamin N. Friedland, Rohith Battina, Raneen Rahhal, John E. Davis, Jr., Irfan S. Khan, Anton Wellstein, and Anna T. Riegel.
2023. "Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells" Cancers 15, no. 6: 1908.
https://doi.org/10.3390/cancers15061908
APA Style
Gallanis, G. T., Sharif, G. M., Schmidt, M. O., Friedland, B. N., Battina, R., Rahhal, R., Davis, J. E., Jr., Khan, I. S., Wellstein, A., & Riegel, A. T.
(2023). Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells. Cancers, 15(6), 1908.
https://doi.org/10.3390/cancers15061908
